Neuronetics, Inc. (NASDAQ: STIM) is a Healthcare company (Medical - Devices) with a market capitalization of $99M. The Maz Rating grades it against the other companies in its sector.
Neuronetics, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $1.28, Neuronetics, Inc. trades at 0.6x sales and 5.2x book value. Over the last twelve months it generated about $160M of revenue and a net loss of $25M. It runs a gross margin of 50.7%, an operating margin of -9.4% and a net margin of -14.4%. It shows return on equity of -127.9%, return on invested capital of -13.6% and a free cash flow yield of -8.4%. On the balance sheet: a debt-to-equity ratio of 4.69 and a current ratio of 2.01. Over the past 52 weeks the share price ranged from $0.80 to $3.44, with a beta of 1.20.
Neuronetics, Inc. does not currently pay a dividend.
8 Wall Street analyst ratings cover the stock: 7 Buy and 1 Hold, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Neuronetics, Inc. functions as a medical technology enterprise with commercialized products, specializing in the creation, enhancement, and global distribution of solutions for individuals experiencing neurohealth conditions, both within the U.S. and abroad. The company's flagship product is the NeuroStar Advanced Therapy System, an in-office, non-surgical, and non-pharmaceutical treatment option available for adult patients diagnosed with major depressive disorder. This sophisticated system utilizes transcranial magnetic stimulation (TMS) to generate a pulsed magnetic field, similar in strength to an MRI, which subsequently induces electrical currents. These currents are specifically engineered to activate brain areas that are key to mood regulation. Neuronetics distributes its offerings directly to psychiatrists through its dedicated sales and client support personnel. Established in 2001, the company's corporate headquarters are situated in Malvern, Pennsylvania.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.
No. As of September 2026, Neuronetics, Inc. (STIM) is classified as NOT HALAL by Maz Vantage: it fails every published Shariah screening standard it could be measured against (AAOIFI, S&P Global, Dow Jones, MSCI and FTSE).
| Standard | Ratios (value / limit) | Result |
|---|---|---|
| AAOIFI | Debt / Mkt Cap (36m) 35.0% / 30% · (Cash+Inv) / Mkt Cap (36m) 12.5% / 30% · Interest income / Revenue 0.00% / 5% | Fail |
| S&P Global | Debt / Mkt Cap (36m) 35.0% / 33% · (Cash+ST Inv) / Mkt Cap (36m) 12.5% / 33% · Receivables / Mkt Cap (36m) 8.32% / 49% · Interest income / Revenue 0.00% / 5% | Fail |
| Dow Jones | Debt / Mkt Cap (24m) 35.0% / 33.33% · (Cash+ST Inv) / Mkt Cap (24m) 12.5% / 33.33% · Receivables / Mkt Cap (24m) 8.32% / 33.33% · Interest income / Revenue 0.00% / 5% | Fail |
| MSCI | Debt / Avg Assets (4Q) 48.2% / 33.33% · (Cash+ST Inv) / Avg Assets (4Q) 16.8% / 33.33% · Receivables / Avg Assets (4Q) 12.0% / 33.33% · Interest income / Revenue 0.00% / 5% | Fail |
| FTSE | Debt / Total Assets 46.8% / 33.33% · (Cash+ST Inv) / Total Assets 16.8% / 33.33% · (Cash+Recv) / Total Assets 27.9% / 33.33% · Interest income / Revenue 0.00% / 5% | Fail |
No. As of September 2026, Neuronetics, Inc. (STIM) is classified as NOT HALAL by Maz Vantage: it fails every published Shariah screening standard it could be measured against (AAOIFI, S&P Global, Dow Jones, MSCI and FTSE).
No. Neuronetics, Inc. is over the AAOIFI limit on Debt / Mkt Cap (36m).
Neuronetics, Inc. reported no interest income in the latest quarter, so there is nothing to purify from its dividend on that basis.
The screen is rerun on each quarterly report; the figures here are from the balance sheet dated September 30, 2026 (Q3 2026). A status can change from one quarter to the next as debt, cash and market value move.
See also the list of halal stocks, halal healthcare stocks, the halal stock screener, the dividend purification calculator and the zakat calculator.
A mechanical screen of published financial ratios and the company's line of business, not a religious ruling. It does not test every revenue stream; check with a scholar you trust.